Could a simple steroid help tiny preemies escape breathing machines?
NCT ID NCT07447739
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving the steroid betamethasone to extremely premature babies (born before 28 weeks) helps them come off breathing machines more easily and lowers their risk of chronic lung disease. About 100 babies will receive either standard NICU care plus betamethasone or standard care alone. Researchers will track breathing progress, growth, and any side effects like high blood sugar or blood pressure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA (BPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maria Fareri Children's Hospital at Westchester Medical Center
Valhalla, New York, 10595, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a higher steroid dose help preterm babies breathe easier?
- Could a simple blood test flag lung risk in preemies?
- Can a steroid shot into the windpipe protect preemies' lungs?
- Could a simple fat supplement protect preemie lungs?
- Could a simple sedation plan transform recovery for ECMO patients?
- Vitamin a shown to protect tiny Preemies' lungs